Literature DB >> 26436940

Type I persistent proatlantal artery associated with fusiform subclavian artery aneurysm: Report of one case.

Krunoslav Buljan, Ivana Hegeduš, Tihana Gilman Kuric, Tamer Salha, Svetlana Tomić, Silva Butković Soldo, Vesna Buljan, Đurđica Šošić.   

Abstract

We report a 61 years old male presenting with a right cerebral infarction, along with a type I persistent left proatlantal artery (PA), which is a form of primitive carotid-basilar anastomosis. The patient had an absence of the ipsilateral vertebral artery (VA) and hypoplasia of the contralateral VA, while the basilar artery was supplied by the PA. Other vascular anomalies present were a fusiform aneurysm of the right subclavian artery, and an A1 segment aplasia of the hypoplastic anterior right cerebral artery, which originated from the anterior communicating artery. To our knowledge these anomalies were not described previously.

Entities:  

Mesh:

Year:  2015        PMID: 26436940     DOI: 10.4067/S0034-98872015000800018

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  3 in total

1.  Basilar vascular system supplied by only right proatlantal intersegmentary artery type 1 with aneurysm and left internal carotid occlusion: a case report and review from the literature.

Authors:  Alessandro Ferrone; Barbara Brogna; Raffaele Giliberti; Pasquale Vassallo; Giuseppe De Magistris
Journal:  Radiol Case Rep       Date:  2016-06-11

Review 2.  Unilateral Aplasia versus Bilateral Aplasia of the Vertebral Artery: A Review of Associated Abnormalities.

Authors:  L Vasović; M Trandafilović; S Vlajković; G Djordjević; M Daković-Bjelaković; M Pavlović
Journal:  Biomed Res Int       Date:  2017-08-28       Impact factor: 3.411

3.  A Type 1 Persistent Proatlantal Artery Originating from the External Carotid Artery Detected by Computed Tomographic Angiography.

Authors:  Yunsuk Choi; Sang Bong Chung; Myoung Soo Kim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2018-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.